Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 17Leukemia, Myeloid, Acute 10Myelodysplastic Syndromes 8Lymphoma, Non-Hodgkin 8Lymphoma 6Leukemia 5Neoplasms, Plasma Cell 4Hodgkin Disease 4Recurrence 3Prostatic Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Hematologic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Primary Myelofibrosis 2Ovarian Neoplasms 2Neoplasms 2Myeloproliferative Disorders 2Lung Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Glioblastoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Renal Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1

Interventions

fludarabine 3Busulfan 3thymoglobulin 2fludarabine phosphate 2Behavior Therapy 2sargramostim 1romiplostim 1duvelisib 1Social Determinants of Health 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dasatinib 1Colony-Stimulating Factors 1Azacitidine 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Lymphoid × Azacitidine × Plasma cell × Clear all
NCT05065866 2025-12-04

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
14 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡